Cabotegravir + Rilpivirine (LA)
HIV-1 Treatment
Approved/Phase 3Active
Key Facts
About ViiV Healthcare
ViiV Healthcare is a unique, HIV-focused pharmaceutical company established as a joint venture by GSK, Pfizer, and Shionogi. It has built a leading portfolio of antiretroviral therapies, including long-acting injectable regimens, and maintains a robust pipeline aimed at treatment, prevention, and cure. The company operates with a deep commitment to the HIV community, leveraging partnerships and implementation science to address unmet needs and health disparities globally.
View full company profileTherapeutic Areas
Other HIV-1 Treatment Drugs
| Drug | Company | Phase |
|---|---|---|
| Next-generation INSTIs & Combos | ViiV Healthcare | Phase 2/Phase 1 |
| Dolutegravir (Tivicay®) | Shionogi | Marketed |